Y-Mabs Therapeutics's total assets for Q2 2025 were $117.21M, an increase of 4.08% from the previous quarter. YMAB total liabilities were $29.72M for the fiscal quarter, a 28.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.